AllianceBernstein’s Alimera Sciences ALIM Stock Holding History

AllianceBernstein’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,850	Closed	-$116K	–	3276
2024 Q2	$116K	Buy	+20,850	New	+$74.1K	﹤0.01%	3107
2015 Q2	–	Sell	-107	Closed	-$8K	–	3298
2015 Q1	$8K	Hold	107	–	–	﹤0.01%	3376
2014 Q4	$9K	Hold	107	–	–	﹤0.01%	3319
2014 Q3	$9K	Sell	107 -106	-50%	-$9.05K	﹤0.01%	3297
2014 Q2	$19K	Buy	+213	New	+$18.9K	﹤0.01%	3240
2014 Q1	–	Sell	-47	Closed	-$3K	–	3689
2013 Q4	$3K	Sell	47 -140	-75%	-$5.71K	﹤0.01%	3195
2013 Q3	$11K	Sell	187 -17	-8%	-$1.07K	﹤0.01%	3148
2013 Q2	$15K	Buy	+204	New	+$11.8K	﹤0.01%	3097

AllianceBernstein's ALIM Position: Q3 2024 in Review

AllianceBernstein sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 20,850 shares — an estimated $116K sold.

AllianceBernstein first reported a position in ALIM in Q2 2013 and held it in 8 quarters. The position peaked at $116K in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

AllianceBernstein reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
AllianceBernstein sold 20,850 Alimera Sciences shares in Q3 2024, an estimated $116K.
AllianceBernstein first reported a position in Alimera Sciences in Q2 2013 and held it in 8 quarters.
AllianceBernstein's Alimera Sciences position peaked at $116K in Q2 2024.
0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on AllianceBernstein's 13F filing for Q3 2024, filed 14 Nov 2024.